(Q44517537)

3 December 2017

title

A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT. (English)

1 reference

3 December 2017

main subject

liver transplantation

1 reference

L Fischer

1

1 reference

3 December 2017

J Klempnauer

2

1 reference

3 December 2017

S Beckebaum

3

1 reference

3 December 2017

H J Metselaar

4

1 reference

3 December 2017

P Neuhaus

5

1 reference

3 December 2017

P Schemmer

6

1 reference

3 December 2017

U Settmacher

7

1 reference

3 December 2017

N Heyne

8

1 reference

3 December 2017

P-A Clavien

9

1 reference

3 December 2017

F Muehlbacher

10

1 reference

3 December 2017

I Morard

11

1 reference

3 December 2017

H Wolters

12

1 reference

3 December 2017

W Vogel

13

1 reference

3 December 2017

T Becker

14

1 reference

3 December 2017

M Sterneck

15

1 reference

3 December 2017

F Lehner

16

1 reference

3 December 2017

C Klein

17

1 reference

3 December 2017

G Kazemier

18

1 reference

3 December 2017

A Pascher

19

1 reference

3 December 2017

J Schmidt

20

1 reference

3 December 2017

F Rauchfuss

21

1 reference

3 December 2017

A Schnitzbauer

22

1 reference

3 December 2017

S Nadalin

23

1 reference

3 December 2017

M Hack

24

1 reference

3 December 2017

S Ladenburger

25

1 reference

3 December 2017

H J Schlitt

26

1 reference

3 December 2017

language of work or name

English

0 references

publication date

11 April 2012

1 reference

American Journal of Transplantation

3 December 2017

published in

1 reference

3 December 2017

volume

12

1 reference

3 December 2017

issue

7

1 reference

3 December 2017

page(s)

1855-1865

1 reference

Chronic renal failure after transplantation of a nonrenal organ

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

Chronic renal dysfunction late after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

Chronic renal dysfunction after liver transplantation in adult patients: prevalence, risk factors, and impact on mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

Independent risk factors and natural history of renal dysfunction in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

Predictors of late kidney dysfunction post-liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

Calcineurin inhibitor minimization protocols in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

Rapamycin: friend, foe, or misunderstood?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

A Decade of Experience Using mTor Inhibitors in Liver Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

Early withdrawal of calcineurin inhibitors and everolimus monotherapy in de novo liver transplant recipients preserves renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

The impact of everolimus on renal function in maintenance liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04049.X

10.1111/J.1600-6143.2012.04049.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference